Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Given Average Rating of “Hold” by Analysts

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) have earned a consensus rating of “Hold” from the sixteen ratings firms that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $21.1538.

ACHC has been the topic of several recent research reports. Bank of America lowered Acadia Healthcare from a “neutral” rating to an “underperform” rating and reduced their price objective for the company from $21.50 to $13.00 in a research report on Wednesday, December 3rd. Raymond James Financial reaffirmed an “outperform” rating and issued a $25.00 target price on shares of Acadia Healthcare in a research note on Thursday, February 26th. Barclays increased their price target on shares of Acadia Healthcare from $14.00 to $20.00 and gave the company an “equal weight” rating in a research report on Tuesday, March 3rd. Guggenheim lowered their price objective on shares of Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating for the company in a report on Monday, February 23rd. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, January 21st.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Principal Financial Group Inc. boosted its stake in shares of Acadia Healthcare by 112.1% during the third quarter. Principal Financial Group Inc. now owns 442,943 shares of the company’s stock valued at $10,967,000 after purchasing an additional 234,107 shares during the period. Vanguard Group Inc. increased its stake in shares of Acadia Healthcare by 7.8% in the third quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock worth $233,166,000 after buying an additional 681,278 shares during the period. Invenomic Capital Management LP increased its stake in shares of Acadia Healthcare by 41.6% in the third quarter. Invenomic Capital Management LP now owns 1,936,396 shares of the company’s stock worth $47,945,000 after buying an additional 568,796 shares during the period. First Citizens Bank & Trust Co. raised its holdings in Acadia Healthcare by 164.1% during the 3rd quarter. First Citizens Bank & Trust Co. now owns 59,123 shares of the company’s stock valued at $1,464,000 after buying an additional 36,733 shares during the last quarter. Finally, Public Sector Pension Investment Board purchased a new stake in Acadia Healthcare during the 3rd quarter valued at $8,919,000.

Acadia Healthcare Stock Performance

Acadia Healthcare stock opened at $22.73 on Friday. Acadia Healthcare has a fifty-two week low of $11.43 and a fifty-two week high of $31.04. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.55 and a current ratio of 1.55. The stock has a market cap of $2.10 billion, a P/E ratio of -1.86, a price-to-earnings-growth ratio of 7.68 and a beta of 0.74. The firm’s fifty day moving average price is $17.71 and its 200-day moving average price is $18.77.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The business had revenue of $821.46 million for the quarter, compared to analysts’ expectations of $800.10 million. During the same quarter in the prior year, the firm earned $0.64 earnings per share. The firm’s revenue was up 6.1% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. On average, equities research analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.